Linda L. Carpenter, MD

TMS in Anxious Depression

January 11, 2023

Patients with anxious depression tend to have more severe depressive symptoms. This study examined the effects of transcranial magnetic stimulation in these patients.

Todd M. Hutton, Scott T. Aaronson, Linda L. Carpenter, et al

Letter to the Editor

Dr McClintock and Colleagues Reply to Consensus Recommendations for rTMS in Depression

February 21, 2018

Shawn M. McClintock, Irving M. Reti, Linda L. Carpenter, et al

Letter to the Editor

Dr McClintock and Colleagues Reply to Roles and Qualifications of TMS Treatment Team Members

February 21, 2018

Shawn M. McClintock, Irving M. Reti, Linda L. Carpenter, et al

Review Article

Adenosylmethionine (SAMe) for Depression

June 28, 2017

Read a systematic review on S-adenosylmethionine (SAMe) for treatment of neuropsychiatric conditions, depression, and comorbid medical conditions.

Anup Sharma, Patricia Gerbarg, Teodoro Bottiglieri, et al

Consensus Statement

Consensus Recommendations for Applying rTMS in MDD

May 23, 2017

To quell any confusion on how best to apply rTMS to treat patients with major depressive disorder, the NNDC's rTMS Task Group and members of the APA's Council on...

Shawn M. McClintock, Irving M. Reti, Linda L. Carpenter, et al

Letter to the Editor

Dr Mischoulon and Colleagues Reply

November 24, 2014

David Mischoulon, Lawrence H. Price, Linda L. Carpenter, et al

Original Research

A Multisite, Naturalistic, Observational Study of Transcranial Magnetic Stimulation for Patients With Pharmacoresistant Major Depressive Disorder: Durability of Benefit Over a 1-Year Follow-Up Period

September 16, 2014

David L. Dunner, Scott T. Aaronson, Harold A. Sackeim, et al

Original Research

A Double-Blind, Randomized, Placebo-Controlled Clinical Trial of S-Adenosyl-l-Methionine (SAMe) Versus Escitalopram in Major Depressive Disorder

December 24, 2013

David Mischoulon, Lawrence H. Price, Linda L. Carpenter, et al

ASCP Corner

Transcranial Magnetic Stimulation for Medication-Resistant Depression

April 15, 2010

Agustin G. Yip, Linda L. Carpenter

Article

Varenicline Augmentation in Depressed Smokers: An 8-Week, Open-Label Study

March 24, 2009

Noah S. Philip, Linda L. Carpenter, Audrey R. Tyrka, et al

Letter to the Editor

Levetiracetam-Induced Depression in a Healthy Adult

July 14, 2006

Lauren M. Wier, Sandra B. Tavares, Audrey R. Tyrka, et al

Original Research

Open-Label Tiagabine Monotherapy for Major Depressive Disorder With Anxiety

January 16, 2006

Linda L. Carpenter, Jordan M. Schecter, Audrey R. Tyrka, et al

TMS in Anxious Depression

Dr McClintock and Colleagues Reply to Consensus Recommendations for rTMS in Depression

Dr McClintock and Colleagues Reply to Roles and Qualifications of TMS Treatment Team Members

Adenosylmethionine (SAMe) for Depression

Consensus Recommendations for Applying rTMS in MDD

Dr Mischoulon and Colleagues Reply

A Multisite, Naturalistic, Observational Study of Transcranial Magnetic Stimulation for Patients With Pharmacoresistant Major Depressive Disorder: Durability of Benefit Over a 1-Year Follow-Up Period

A Double-Blind, Randomized, Placebo-Controlled Clinical Trial of S-Adenosyl-l-Methionine (SAMe) Versus Escitalopram in Major Depressive Disorder

Transcranial Magnetic Stimulation for Medication-Resistant Depression

Varenicline Augmentation in Depressed Smokers: An 8-Week, Open-Label Study

Levetiracetam-Induced Depression in a Healthy Adult

Open-Label Tiagabine Monotherapy for Major Depressive Disorder With Anxiety

ELSEWHERE:

FOLLOW US:

Linda L. Carpenter, MD

TMS in Anxious Depression

Dr McClintock and Colleagues Reply to Consensus Recommendations for rTMS in Depression

Dr McClintock and Colleagues Reply to Roles and Qualifications of TMS Treatment Team Members

Adenosylmethionine (SAMe) for Depression

Consensus Recommendations for Applying rTMS in MDD

Dr Mischoulon and Colleagues Reply

A Multisite, Naturalistic, Observational Study of Transcranial Magnetic Stimulation for Patients With Pharmacoresistant Major Depressive Disorder: Durability of Benefit Over a 1-Year Follow-Up Period

A Double-Blind, Randomized, Placebo-Controlled Clinical Trial of S-Adenosyl-l-Methionine (SAMe) Versus Escitalopram in Major Depressive Disorder

Transcranial Magnetic Stimulation for Medication-Resistant Depression

Varenicline Augmentation in Depressed Smokers: An 8-Week, Open-Label Study

Levetiracetam-Induced Depression in a Healthy Adult

Open-Label Tiagabine Monotherapy for Major Depressive Disorder With Anxiety

Celebrating85 Years

Subscribe to readmore articles

Celebrating
85 Years

Subscribe to read
more articles